INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
AJ

Allan Jonathan

GENERAL COUNSEL & CORP SECCIK 0001966716

EDGAR filingsOpen in network
Disclosed transactions26
Buys / sells0 / 20
Max Insider Score36
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$17K
627 sh
Oct 2, 2026Oct 2, 2026
traded Oct 2, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Stoke Therapeutics, Inc.GENERAL COUNSEL & CORP SEC · Dec 3, 2025
2
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL
$44K
1,457 sh
Jun 16, 2026
Jun 18, 2026
traded Jun 16, 2026
+2d
SEC FORM 4

Evidence

27
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$292K
8,692 sh
Mar 20, 2026Mar 24, 2026
traded Mar 20, 2026
+4dSEC FORM 4

Evidence

13
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
601 sh
Mar 20, 2026Mar 24, 2026
traded Mar 20, 2026
+4dSEC FORM 4

Evidence

36
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$81K
2,476 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC FORM 4

Evidence

36
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$60K
1,791 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC FORM 4

Evidence

36
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$132K
4,222 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC FORM 4

Evidence

29
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$11K
334 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC FORM 4

Evidence

29
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$2,365
72 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC FORM 4

Evidence

2
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Grant or award
A—
53.0K sh
Feb 17, 2026Feb 19, 2026
traded Feb 17, 2026
+2dSEC FORM 4

Evidence

2
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Grant or award
A—
35.0K sh
Feb 17, 2026Feb 19, 2026
traded Feb 17, 2026
+2dSEC FORM 4

Evidence

12
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
1,300 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC FORM 4

Evidence

15
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$87K
2,678 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC FORM 4

Evidence

8
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$31K
1,004 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC FORM 4

Evidence

3
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
6,000 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC FORM 4

Evidence

11
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$6,075
194 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC FORM 4

Evidence

19
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$169K
5,437 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC FORM 4

Evidence

0
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
6,000 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC FORM 4

Evidence

11
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$25K
824 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC FORM 4

Evidence

15
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$74K
2,344 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC FORM 4

Evidence

31
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$43K
1,394 sh
Dec 3, 2025Dec 3, 2025
traded Dec 3, 2025
+0dSEC FORM 4

Evidence

9
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Option exercise
M—
12.4K sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC FORM 4

Evidence

27
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$27K
898 sh
Dec 3, 2025Dec 3, 2025
traded Dec 3, 2025
+0dSEC FORM 4

Evidence

35
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$42K
1,416 sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC FORM 4

Evidence

31
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$26K
868 sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC FORM 4

Evidence

21
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Option exercise
M—
12.4K sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC FORM 4

Evidence